MapLight Therapeutics, Inc. (MPLT)
7.25
+0.18
(+2.55%)
USD |
NASDAQ |
Nov 13, 16:00
7.25
0.00 (0.00%)
After-Hours: 19:59
MapLight Therapeutics Total Assets (Quarterly) : 368.35M for June 30, 2026
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 368.35M |
| March 31, 2026 | 418.79M |
| December 31, 2025 | 479.51M |
| September 30, 2025 | 257.22M |
| Date | Value |
|---|---|
| June 30, 2025 | 84.12M |
| March 31, 2025 | 111.57M |
| June 30, 2024 | |
| March 31, 2024 | 192.57M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Oncolytics Biotech, Inc. | 5.832M |
| Sangamo Therapeutics, Inc. | 59.96M |
| Sarepta Therapeutics, Inc. | 3.166B |
| Anixa Biosciences, Inc. | 15.07M |
| Vicapsys Life Sciences, Inc. | 0.1325M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 20.05M |
| Shareholders Equity (Quarterly) | 348.30M |
| Debt to Equity Ratio | 0.0057 |
| Current Ratio | 16.52 |
| Net Debt Paydown Yield | 0.05% |